| Date | Title | Description |
| 25.10.2024 | Bactiguard's Strategic Shift: A New Era in Infection Prevention | Bactiguard Holding AB is navigating through turbulent waters. The company’s latest interim report for the third quarter of 2024 reveals a significant turnaround. With total revenue soaring to SEK 73.9 million, a 49.4% increase from the prev... |
| 24.10.2024 | Bactiguard Holding AB’s interim report third quarter 2024 | Bactiguard Holding AB’s interim report third quarter 2024
Thu, Oct 24, 2024 07:00 CET Report this content
Bactiguard delivers positive EBITDA and initiates review of 2028 financial targets due to previously announced agreement termination T... |
| 23.10.2024 | BD and College of American Pathologists Celebrate 10 years of Collaboration Dedicated to Laboratory Quality Improvement | New Delhi, Delhi, India
BD, global leader in diagnostic devices, and the CAP (College of American Pathologists), global leader in medical laboratory EQA (External Quality Assessment) and accreditation services, celebrated 10 years of collab... |
| 07.10.2024 | Whatfix Announces USD 58 Million (Rs. 485 Crores) Liquidity Event for its Employees and Investors | Bengaluru, Karnataka, India
Whatfix, a pioneer in the “userization” of application technology, maximizing ROI on enterprise tech stacks, has announced its fourth liquidity program of $58 million. The company facilitated liquidity for employ... |
| 27.09.2024 | Navigating the Crossroads of Innovation and Illicit Trade in India | India stands at a pivotal moment. On one side, the promise of innovation in the medical technology sector shines brightly. On the other, a shadow looms over the economy due to rampant illicit trade. These two narratives are intertwined, sha... |
| 27.09.2024 | Everstone-backed medical devices maker Integris appoints new CEO | Probir Das, group CEO, Integris Health Pvt. Ltd
Integris Health Pvt Ltd, which manufactures and distributes cardiac stents and cardiovascular medical devices under the name Translumina Therapeutics, said Friday it has appointed former chief... |
| 17.09.2024 | Navigating the Complex Landscape of Healthcare Technology: A Dual Focus on User Experience and Patient Safety | In the realm of healthcare, technology is a double-edged sword. On one side, it promises to enhance patient outcomes and streamline workflows. On the other, it poses risks if not designed with care. The challenge lies in balancing user expe... |
| 17.09.2024 | 11 Hospitals Across India Successfully Complete PRIME Program for the 5th Year in a Row | New Delhi, Delhi, India
Preventing risk of infection and medication error in healthcare settings is a key imperative to ensure patient and healthcare worker safety. Aligned with this and given the focus on safe medical practices in hospital... |
| 12.09.2024 | Balancing User Experience and Technical Complexity in Surgical Software Design | Neeraj Mainkar, VP of Software Engineering & Advanced Technology at Proprio
In healthcare, the impact of well-designed medical devices reaches far beyond their physical form. When these devices are thoughtfully crafted with the end-user... |
| 06.09.2024 | Weekly Recap: 10 Health Press Releases You Might Have Missed | A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including a new COVID-19 vaccine, Prostate Cancer Awareness Month news and Walk to End Alzheimer's.
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- With thousand... |
| 04.09.2024 |
Edwards Lifesciences starts global layoffs | Edwards Lifesciences (NYSE: EW) + has initiated layoffs across the device developer’s global footprint after completing the $4.2 billion sale of its Critical Care business to Becton, Dickinson and Co.
About 3% of the company’s workforce wil... |
| 03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share
Tweet
Share
Share
Email
In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
| 29.08.2024 | The Surge of Cardiac Surgery: A Market in Motion | The global cardiac surgery market is on the rise. It’s a lifeline in a world grappling with cardiovascular diseases (CVDs). These diseases are silent killers, claiming over 17 million lives each year. As technology advances, the market is p... |
| 28.08.2024 | Cardiac Surgery Market to Exceed $24B Due to Global Shift Towards Minimally Invasive Surgeries (TAVI/TAVR and TMVr) | iData Research | VANCOUVER, BC, Aug. 28, 2024 /PRNewswire/ - In a world, where cardiovascular diseases (CVDs) remain a leading cause of death, the global cardiac surgery market has emerged as a cornerstone of life-saving interventions, driven by innovations... |
| 08.08.2024 | BD to Present at Wells Fargo 2024 Healthcare Conference | FRANKLIN LAKES, N.J., Aug. 8, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2024 Healthcare Conference on Wednesday,... |
| 05.08.2024 | ASP Health Inc. Expands Executive Team with its First National Sales Director | Patrick Moan, National Sales Director, ASP Health
Medical Product Sales and Marketing Veteran Patrick Moan, MBA, to Build Company's Hybrid Sales Force
NORTHBROOK, Ill., Aug. 5, 2024 /PRNewswire-PRWeb/ -- ASP Health Inc., a private medical d... |
| 01.08.2024 | BD Reports Third Quarter Fiscal 2024 Financial Results | Strong Margin Execution Drives Performance in Quarter
Revenue of $5.0 billion as reported, adjusted revenue of $5.1 billion, driven by strong organic revenue growth
GAAP and adjusted diluted EPS of $1.68 and $3.50 grew 23.5% and 18.2%, resp... |
| 31.07.2024 | Amsel Medical and Genpact: Navigating New Waters in Healthcare Innovation | In the ever-evolving landscape of healthcare, two companies are making waves: Amsel Medical and Genpact. Each is charting its own course, but both share a common goal: improving patient outcomes through innovative solutions. Amsel Medical r... |
| 30.07.2024 | Amsel Medical Announces Appointment of Chief Executive Officer | CAMBRIDGE, Mass., July 30, 2024 /PRNewswire/ -- Amsel Medical Corporation is pleased to announce the appointment of James A. Heinz, MSL as Chief Executive Officer of Amsel effective July 30, 2024. Mr. Heinz began his service in October 2023... |
| 29.07.2024 | Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company | Genpact's deep domain knowledge and data expertise enables embecta's vision to make a meaningful impact in the healthcare sector
NEW YORK, July 29, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm de... |
| 23.07.2024 | BD Board Declares Dividend | FRANKLIN LAKES, N.J., July 23, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per com... |
| 16.07.2024 | Bactiguard Holding AB’s interim report second quarter 2024 | Bactiguard Holding AB’s interim report second quarter 2024
Tue, Jul 16, 2024 07:00 CET Report this content
License revenues and EBITDA stabilizing Second quarter 2024 (April – June) Total revenue amounted to SEK 60.9 (51.2) million, an incr... |
| 03.07.2024 | BD to Announce Financial Results for its Third Quarter of Fiscal 2024 | FRANKLIN LAKES, N.J., July 3, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2024 ... |
| 20.06.2024 | BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts | FRANKLIN LAKES, N.J., June 20, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to discuss quarterly financial results on the fo... |
| 12.06.2024 | Senior life science and medical specialists join SmartCella’s Board of Directors | Senior life science and medical specialists join SmartCella’s Board of Directors
Wed, Jun 12, 2024 09:00 CET Report this content
SmartCella Holding AB (“SmartCella”) held its 2024 Annual General Meeting on June 10. The company welcomed inve... |
| 09.06.2024 | US’ Memorial Sloan Kettering Cancer Centre builds on India-connect at multiple levels | Close to two years since the United States-based, Memorial Sloan Kettering Cancer Centre, started its facility in Chennai, the 140-year-old organisation, is looking to take the relationship forward at educational, and research levels, inclu... |
| 03.06.2024 | BD Acquires Edwards Lifesciences’ Critical Care Unit for $4.2B to Strengthen Smart Connected Care Portfolio | What You Should Know:
– Becton, Dickinson and Company (BDX: NYSE), a global leader in medical technology, announced today a definitive agreement to acquire Edwards Lifesciences’ (EW: NYSE) Critical Care product group for $4.2 billion in cas... |
| 29.05.2024 | Wockhardt Q4 results: Reports net loss of ₹177 crore; antibiotic products show progress | Drugmaker Wockhardt Limited posted a reduced net loss at ₹177 crore for the three month period ended March 31, 2024, from a net loss of ₹237 crore in the same period last year.
In the current reporting period, the company recognized an impa... |
| 28.05.2024 | BD Partners with Healthians to Increase Access to Cervical Cancer Screening in India | New Delhi, Delhi, India
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced a strategic partnership with Healthians, India’s premier diagnostics service provider, to advance cervical cancer scree... |
| 07.05.2024 | Revolutionizing B2B Communication with AI: Tekst's €700K Funding Boost | Ghent-based Tekst, a cutting-edge AI platform, secures €700K from Entourage to expand its reach in Europe. Founded by ambitious innovators Wouter Janssen and Tiebe Parmentier, Tekst aims to streamline B2B communication through advanced auto... |
| 07.05.2024 | BD Launches the TB Guardianship Program | New Delhi, Delhi, India
To further enhance knowledge exchange amongst healthcare professionals on effective TB diagnostic practices, BD (Becton, Dickinson, and Company), a Corporate TB Pledge holder has recently launched the ‘TB Guardianshi... |
| 06.05.2024 | 2024 Gartner® Voice of the Customer Report Named Whatfix a Customers' Choice for Digital Adoption Platforms | Bangalore, Karnataka, India
Whatfix, the global digital adoption platforms (DAP) leader, has been recognized as a Customers’ Choice in the Gartner report. This distinction placed Whatfix in the top-right section of Peer Insights Quadrant, t... |
| 06.05.2024 | Babson Diagnostics partners with Cynergy to oversee its BetterWay blood test | BetterWay blood testing will launch in Texas later this year before rolling out nationally
Blood testing informs 70% of clinical decision-making, yet it hasn’t changed much in over 70 years: patients still visit a collection service center ... |
| 03.05.2024 | Belgium’s AI-based B2B communication platform Tekst raises €700K from Pieterjan Bouten’s Entourage | Read this article in:
Ghent-based Tekst, an AI platform that analyses and automates all B2B communication internally and externally, has secured €700K from Entourage to grow and sell their tech more widely in Europe.
Entourage is a Venture ... |
| 01.05.2024 |
Advice for building a medtech career inside a big company from BD CTO Elizabeth McCombs | BD EVP and Chief Technology Officer Elizabeth McCombs [Photo courtesy of BD]In the opening keynote for DeviceTalks Boston 2024 today, BD (NYSE:BDX) + EVP and Chief Technology Officer Elizabeth McCombs offered advice for building a medtech c... |
| 30.04.2024 | BD Board Declares Dividend | FRANKLIN LAKES, N.J., April 30, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per co... |
| 29.04.2024 | BD to Present at Bank of America Securities Health Care Conference 2024 | FRANKLIN LAKES, N.J., April 29, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference ... |
| 25.04.2024 | Bactiguard Holding AB’s interim report first quarter 2024 | Bactiguard Holding AB’s interim report first quarter 2024
Thu, Apr 25, 2024 08:00 CET Report this content
Strategic transformation concluded and new leadership in place First quarter 2024 (January – March) Total revenue amounted to SEK 58.8... |
| 23.04.2024 | BD India's Concerted Commitment Towards Creating Awareness About Venous Diseases | New Delhi, Delhi, India
To create awareness and enable knowledge-sharing around Venous diseases, in order to drive better patient care BD (Becton, Dickinson, and Company) conducted roadshows across New Delhi, Mumbai and Bangalore recently. ... |
| 04.04.2024 | BD to Announce Financial Results for its Second Quarter of Fiscal 2024 | FRANKLIN LAKES, N.J., April 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 202... |
| 28.03.2024 | BD India Launches UltraTouch™; a New Age blood Collection Device Targeted to Minimize Patient Pain | New Delhi, Delhi, India
To minimize patient pain and discomfort as well as enable single prick success during blood collection process, BD (Becton, Dickinson, and Company) has recently launched the BD Vacutainer® UltraTouch™ Push Button Blo... |
| 15.03.2024 | Zeus Names New Chief Executive Officer | Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies, names Padraic "Paddy" O'Brien as new CEO
O'Brien joins Zeus at a pivotal moment as the company enters a ... |
| 14.03.2024 | Global Medication Management System Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors | Global Medication Management System Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors
The Business Research Company's Medication Management System Global Market Report 2024 – Market Size, Trends, And Global Forecast ... |
| 14.03.2024 | Mechanical Ventilator Market Size Expected To Reach $15.13 Billion By 2028 | Mechanical Ventilator Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033
The Business Research Company’s Mechanical Ventilator Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033
The me... |
| 13.03.2024 | Pre-Filled Syringes Market 10 Year Forecast Report 2024-2034: Growing Movement Towards Home-based Healthcare and Innovative Solutions Addressing the Escalating Need for Pre-Filled Syringes | - |
| 12.03.2024 | Hospital-Acquired Sepsis: Twenty Percent Caused by Central-Lines, Including PICCs | CLABSI and non-CLABSI HOB cases are associated with significant increases in morbidity, mortality, and cost.
Twenty percent of hospital acquired bloodstream infections are caused by lines and Dr. Yu’s study show these patients are the sicke... |
| 11.03.2024 | In Vitro Diagnostics (IVD) Market is Expected to Reach $130.1 Billion by 2030 - Exclusive Report by Meticulous Research® | According to Meticulous Research®, the global in vitro diagnostics market is expected to register a CAGR of 4.6% from 2023 to reach $130.1 billion by 2030. REDDING, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- According to a new mark... |
| 11.03.2024 | Global Ultrasonic Nebulizer Market: Analyzing Growth Trends, Insights and Forecasts to 2030 | CoherentMI | The Global Ultrasonic Nebulizer Market size is expected to reach US$ 325.6 Million by 2030, from US$ 218.3 Million in 2023, at a CAGR of 5.9% during the forecast period.”
— CoherentMIBURLINGAME, CA 94010, UNITED STATES, March 11, 2024 /EINP... |
| 11.03.2024 | Censinet to Recognize Cybersecurity Transparent Healthcare Organizations at HIMSS 2024 | Company to Present Summary Findings from 2024 Benchmarking Study and Lead Discussions on Strengthening Resiliency to Third-Party Risk
As third-party vendors face intensifying scrutiny going forward, Censinet is proud to recognize twelve new... |
| 11.03.2024 | Infusion Pump Software Market to Cross USD 1660 Million by 2030 | Infusion Pump Software Market
Infusion Pump Software Market Analysis, Industry Overview and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- The Global Infusion Pump Software Market is expected to reach 1660... |
| 11.03.2024 | BD India's Concerted Commitment Towards Creating Awareness on Cervical Cancer | Delhi, India
To create awareness and enable knowledge-sharing around cervical cancer screening, especially the benefits of early screening with liquid-based cytology and human papillomavirus (HPV) DNA testing, BD (Becton, Dickinson, and Com... |
| 08.03.2024 | Surgical Retractors Market to Hit USD 3.17 Billion by 2030 - Exclusive Report by SNS Insider | Surgical Retractors Market
Surgical Retractors Market Analysis, Size, Share, Trends, Industry Overview and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 8, 2024 /EINPresswire.com/ -- The Global Surgical Retractors Market is expected to... |
| 07.03.2024 | Blood Collection Tubes Market Size is Projected to Reach USD 3.6 billion by 2031, Grow at a 5.4% CAGR| Analysis Report by Transparency Market Research, Inc. | - |
| 07.03.2024 | Pre-Filled Syringes market is estimated to grow at a CAGR of 9.5% by 2034: Visiongain | - |
| 06.03.2024 | Global Prefilled Syringe Industry Report 2023-2030: A $15+ Billion Opportunity with Strategic Collaborations and Product Launches Fueling Expansion | - |
| 06.03.2024 | Prostatic Catheter Market Size to Hit US$ 372.3 Million by 2034: Fact.MR Analysis | - |
| 05.03.2024 | Veterinary Disposables Global Market Report 2024 | - |
| 04.03.2024 | Rising Demand and Advancements in Europe IVD Market 2024: Assisted Reproductive Technology for Fertility Solution | Europe In Vitro Diagnostics Market 2024
Demand forin vitro diagnosticsis on therise, owing to surge in prevalence of various chronic diseases which require use of IVD tests for diagnosis
PORTLAND, OREGON, UNITED STATES, March 4, 2024 /EINPr... |
| 30.01.2024 | BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing | AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions
BD, a leading global medical technology company, and Techcyte, a world leader in artificial in... |
| 06.12.2023 | BD India's 'Safety-First' Initiative Brings Spotlight on Healthcare Worker Safety | Kolkata, West Bengal, India
To bring the focus on the role of safety engineered devices in prevention of needle stick injuries during infusion therapy BD India launched its Safety-First Initiative during the 11th Infusion Nurses Society (IN... |
| 17.11.2023 | BD India Installs its First Spectral Cell Sorter with High-Speed Cell Imaging in South Asia | New Delhi, Delhi, India
To celebrate the inauguration of its first image enabled high-speed spectral flow cytometry sorting facility in South Asia, BD Life Sciences-Biosciences, a segment of BD (Becton Dickinson and Company) in association ... |
| 06.11.2023 | 50 Years Journey of Flow Cytometry Technology Innovations Celebrated by BD India | New Delhi, Delhi, India
To celebrate the innovative journey of 50 years of FACS (fluorescence-activated cell sorter), BD Life Sciences-Biosciences, a segment of BD (Becton Dickinson and Company), conducted a scientific exchange and networki... |
| 29.06.2023 | BD India's Pledge for Safety Initiative Launched with a 'Safety Flame' March from Ruby Hall Clinic | New Delhi, Delhi, India
To enhance awareness around the importance of safety protocols, practices, and technologies to deliver optimum Patient and clinical outcomes as well as enable knowledge-sharing of best practices around this key area,... |
| 22.06.2023 |
Brooke Story to become president of Surgery business at BD | Brooke Story
BD (NYSE: BD) + announced today that it named Brooke Story president of its Surgery business unit.
Story’s responsibilities include driving the strategic, operational and commercial performance of the business unit. She reports... |
| 20.06.2023 | 20 Expert Ways To Craft A Successful Product Expansion Strategy | getty |
| 16.06.2023 | BD India Initiated Workshop Aims to Achieve Consensus in Standardizing AML-MRD Assay by Flow Cytometry Testing | New Delhi, Delhi, India
To achieve a consensus on a suitable panel and analysis strategy to report Acute Myeloid Leukemia – Measurable Residual Disease (AML-MRD) by flow cytometry, BD Life Sciences-Biosciences, a segment of BD (Becton, Dick... |
| 11.05.2023 | BD India Partners with Sehgal Path Lab to Launch Third Clinical CoE in Flow Cytometry for Clinical Research | New Delhi, Delhi, India
BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson, and Company), in collaboration with Sehgal Path Lab recently launched its Center of Excellence (CoE) in Flow Cytometry for clinical research in Mumbai... |
| 03.05.2023 | BD Recognized by DiversityInc as a Top U.S. Company for Diversity in 2023 List | FRANKLIN LAKES, N.J., May 3, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) BDX, a leading global medical technology company, today announced that it has been named a "Noteworthy Company" in DiversityInc's annual ranking ... |
| 28.03.2023 | BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research | SINGAPORE, March 28, 2023 /PRNewswire/ -- Becton Dickinson Holdings Pte Ltd (BD), a global leader in life science technologies, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, hav... |
| 20.02.2023 | BD India and the HOPE Foundation Helping Upskill Young Adults | Delhi, India
Aligned with the Government of India’s Skill Development Mission to strengthen existing skills and make the youth self-reliant, Becton Dickinson (BD) India, in partnership with the HOPE Foundation is helping upskill young adult... |
| 04.02.2023 | On World Cancer Day, BD India Launches the PortShala Microsite for Healthcare Professionals and Patients | New Delhi, Delhi, India
Aligned with its commitment to patient safety, BD (Becton, Dickinson, and Company), launched a microsite https://www.bdportshala.com for healthcare professionals and patients on World Cancer Day. It is also the secon... |
| 30.01.2023 | BD India and INS Celebrate and Recognize IV Nurses Day through Webinar Series | New Delhi, Delhi, India
On the occasion of Infusion Nurses Day, BD (Becton, Dickinson, and Company) in partnership with the Infusion Nurses Society (INS) India-US Affiliate organized a series of webinars for Infusion nurses and Infection co... |
| 19.12.2022 | BD India Hosted Discussion Forum on Cervical Cancer Screening Provides Best Practices Knowledge-Sharing Platform to Pathologists and Gynecologists | New Delhi, Delhi, India
To enable knowledge-sharing around Cervical cancer screening including the benefits of early screening with extended genotyping, BD (Becton, Dickinson, and Company) recently organized the ‘Shape the future of Cervica... |
| 09.12.2022 | BD Life Sciences - Biosciences Facilitates Knowledge-sharing Platform for Laboratory Personnel | Vellore, Tamil Nadu, India
BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson, and Company) in collaboration with The Cytometry Society of India, Christian Medical College - Vellore organized a 2-day workshop for laboratory pe... |
| 10.11.2022 | Here’s what health tech leaders want Baltimore startups to know about partnerships | With world-class hospital systems and healthcare networks proliferating in the region, Baltimore has become an increasingly important hub for healthcare innovation.
And with so much money to be made in the life sciences sector, the Baltimor... |
| 01.10.2022 | BD Announces Voluntary Recall of ChloraPrep™ 3 mL Applicator in Specific U.S. Territories and Countries | Summary
Company Announcement Date: August 07, 2020 FDA Publish Date: August 10, 2020 Product Type: Drugs Reason for Announcement:
Recall Reason Description
Potential fungal contamination - Aspergillus penicillioides Company Name: (Becton, D... |
| 31.08.2022 | BD India Launches Rapid Molecular Technique for Detecting Multidrug-resistant Tuberculosis (MDR-TB) and other Infectious Diseases | New Delhi, Delhi, India
To enable clinicians to rapidly test for TB and multidrug resistance as a first-line test, BD Diagnostics, a segment of BD Lifesciences (Becton, Dickinson, and Company), today introduced the BD MAX™ molecular diagnos... |
| 11.08.2022 | Becton Dickinson Recalls Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits, and Intraosseous Powered Drivers for Issues That May Cause Delayed Treatment Delivery | The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product
Product Name: BD Intraosseous Needle Set Kits, BD Intraosseous Manual Driver Kits, ... |
| 13.07.2022 | BD-India Launches SANKALP - A Catalytic Effort to Support the Goal of Eliminating Tuberculosis | Rewari, Haryana, India
To support the goal of eliminating Tuberculosis elimination in India by 2025, Becton Dickinson (BD) India has launched SANKALP - a ‘Pledge to Fight TB Together’.
Rewari Deputy Commissioner Shri Ashok Kumar Garg, IAS a... |
| 20.05.2022 | 'Advances in Clinical Flow Cytometry' Roadshow by BD Provides Rich Knowledge-sharing Platform to Clinicians | New Delhi, Delhi, India
To enable knowledge-sharing of best practices and technological advancement on clinical applications of flow cytometry, BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson and Company) recently organized... |
| 11.02.2022 | BD Life Sciences - Biosciences Conducts a User Group Conference "Advances in Clinical Flow Cytometry (ACFC) in the Commemoration of World Cancer Day" | New Delhi, Delhi, India
To commemorate World Cancer Day observed each year on 4th February, Life Sciences-Biosciences, a segment of BD (Becton, Dickinson and Company) organized a virtual clinical user group meeting on “Conceptual and practi... |
| 08.02.2022 | BD Collaborates with ReturnSafe to Help Employers Manage COVID-19 Testing | FRANKLIN LAKES, N.J., Feb. 8, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with ReturnSafe, the all-in-one software solution for COVID-19 e... |
| 04.02.2022 | Chemoports Can be a Boon for Cancer Patients During Pandemic Times | Mumbai, Maharashtra, India
The pandemic has put a renewed focus on the well-being of patients who are suffering from life-threatening ailments and diseases and need to seek their regular course of treatment at hospitals. In such circumstanc... |
| 04.02.2022 | Parisian startup revolutionising skin cancer screening raises €5 million to accelerate European rollout | Skin cancers affect over 5 million people worldwide each year and patient prognosis continues to be highly dependent on the timing of diagnosis. Attempting to speed up the diagnosis process is Paris-based medtech company Damae Medical. It h... |
| 03.02.2022 | BD REPORTS FIRST QUARTER FISCAL 2022 FINANCIAL RESULTS | FRANKLIN LAKES, N.J., Feb. 3, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal year 2022, which ended December 31, 2021... |
| 02.02.2022 | BD Board of Directors Approves embecta Spinoff and Declares Distribution of embecta Stock | FRANKLIN LAKES, N.J., Feb. 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has approved the planned spinoff of its diabetes care bus... |
| 01.02.2022 | BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A. | FRANKLIN LAKES, N.J., Feb. 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of Cytognos, a privately held company headquart... |
| 26.01.2022 | New Study Finds Up to One-Third of Women Receive Clinical Misdiagnosis of Vaginitis | FRANKLIN LAKES, N.J., Jan. 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the outcome of a peer-reviewed study published in the journal of Obstetrics &am... |
| 11.01.2022 | BD Commemorates 10th Anniversary of its Initiative FITTER - Forum for Injection Technique & Therapy Expert Recommendations | New Delhi | Mumbai, India
11th January every year is observed as Insulin Injection Day and January this year marks the 100th Anniversary of Insulin Injection. Insulin therapy is a crucial aspect of diabetes management. Even though, India is... |
| 11.01.2022 | BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices | FRANKLIN LAKES, N.J., Jan. 11, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with Pfizer Inc. and global charitable foundation Wellcome to b... |
| 07.01.2022 | BD Announces Change to Virtual 2022 Annual Meeting of Shareholders | FRANKLIN LAKES, N.J., Jan. 6, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that in the interest of the health and safety of its shareholders, directors, of... |
| 07.01.2022 | BD Introduces Smart Connected Robotics to Automate Microbial Identification | FRANKLIN LAKES, N.J., Jan. 7, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration... |
| 23.12.2021 | BD Acquires Scanwell Health, Inc. to Expand and Scale Digital At-Home Testing | BD, a leading global medical technology company, announced it has completed the acquisition of privately held Scanwell Health Inc., a leader in smartphone-enabled at-home medical tests.
BD collaborated with Scanwell to develop the app used ... |
| 22.12.2021 | BD Announces New Distribution and Retail Partners for BD Veritor™ At-Home COVID-19 Test | FRANKLIN LAKES, N.J., Dec. 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical company, today announced the BD Veritor™ At-Home COVID-19 Test is now available for purchase through Everly Health,... |
| 17.12.2021 | BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs | FRANKLIN LAKES, N.J., Dec. 17, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to include a new MX instrument for high-thro... |
| 09.12.2021 | BD Acquires Tissuemed, Ltd. To Add Advanced Sealant To Its Portfolio Of Surgical Solutions | FRANKLIN LAKES, N.J., Dec. 9, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, E... |
| 24.11.2021 | BD Names Francesca DeMartino as Senior Vice President of Investor Relations | FRANKLIN LAKES, N.J., Nov. 24, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Francesca DeMartino has been named senior vice president of investor relations ... |
| 12.11.2021 | BD to Highlight Progress Against BD 2025 Strategy and Plans for Long-Term Growth | FRANKLIN LAKES, N.J., Nov. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will begin its Investor Day at 8 a.m. ET today to share how it plans to leverage the breadth an... |
| 04.11.2021 | BD Board Increases Dividend for 50th Consecutive Year, Authorizes 10 Million Additional Share Repurchases | FRANKLIN LAKES, N.J., Nov. 4, 2021 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, an increase of 4.8% from the previous quarter. The divi... |
| 04.11.2021 | BD Announces Fourth Fiscal Quarter And Full Year 2021 Results; Issues Fiscal Year 2022 Guidance | FRANKLIN LAKES, N.J., Nov. 4, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2... |
